Ani Pharmaceuticals (ANIP) EBT Margin (2011 - 2026)
Ani Pharmaceuticals (ANIP) reported EBT Margin of 16.94% for Q1 2026, up 680.0% on a YoY basis from 2.17% in Q1 2025, and up 32.94% sequentially from 12.74% in Q4 2025.
Ani Pharmaceuticals (ANIP) EBT Margin (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals (ANIP) has 16 years of EBT Margin data on file, last reported at 16.94% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 680.0% year-over-year to 16.94%; the trailing twelve-month figure through Mar 2026 stood at 12.56% (up 1665.0% YoY), and the FY2025 full-year result was 10.84%, up 1446.0% from the prior year.
- EBT Margin rose to 16.94% in Q1 2026, from 12.74% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 18.43% in Q1 2024 to a low of 40.17% in Q1 2022.
- A 5-year average of 1.32% and a median of 2.03% in 2023 frame the typical range for EBT Margin.
- Peak annual rise in EBT Margin reached 4452 bps in 2022, while the deepest fall reached 4085 bps in 2022.
- Tracing ANIP's EBT Margin over 5 years: stood at 6.12% in 2022, then soared by 112 bps to 0.72% in 2023, then sank by 1104 bps to 7.22% in 2024, then jumped by 276 bps to 12.74% in 2025, then jumped by 33 bps to 16.94% in 2026.
- Business Quant data shows ANIP's EBT Margin at 16.94% in Q1 2026, 12.74% in Q4 2025, and 14.84% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn | 16.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.94% |
| Dec 31, 2025 | 12.74% |
| Sep 30, 2025 | 14.84% |
| Jun 30, 2025 | 4.98% |
| Mar 31, 2025 | 10.14% |
| Dec 31, 2024 | -7.22% |
| Sep 30, 2024 | -21.23% |
| Jun 30, 2024 | -1.66% |
| Mar 31, 2024 | 18.43% |
| Dec 31, 2023 | 0.72% |
| Sep 30, 2023 | 8.73% |
| Jun 30, 2023 | 4.50% |
| Mar 31, 2023 | 2.03% |
| Dec 31, 2022 | -6.12% |
| Sep 30, 2022 | -14.58% |
| Jun 30, 2022 | -25.48% |
| Mar 31, 2022 | -40.17% |
| Dec 31, 2021 | -50.64% |
| Sep 30, 2021 | -13.64% |
| Jun 30, 2021 | -37.43% |